Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Inventory Average (2019 - 2025)

Sunshine Biopharma (SBFM) has disclosed Inventory Average for 7 consecutive years, with $13.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory Average rose 47.9% year-over-year to $13.5 million, compared with a TTM value of $13.5 million through Sep 2025, up 47.9%, and an annual FY2024 reading of $8.5 million, up 88.51% over the prior year.
  • Inventory Average was $13.5 million for Q3 2025 at Sunshine Biopharma, up from $12.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $13.5 million in Q3 2025 and bottomed at $25215.5 in Q1 2021.
  • Average Inventory Average over 5 years is $4.8 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Inventory Average soared 2337.76% in 2023, then surged 47.9% in 2025.
  • Year by year, Inventory Average stood at $88480.0 in 2021, then skyrocketed by 1911.52% to $1.8 million in 2022, then soared by 188.01% to $5.1 million in 2023, then surged by 105.81% to $10.5 million in 2024, then rose by 28.36% to $13.5 million in 2025.
  • Business Quant data shows Inventory Average for SBFM at $13.5 million in Q3 2025, $12.4 million in Q2 2025, and $11.6 million in Q1 2025.